NYSE Content Advisory: Pre-Market update + Wall Street braces for Nvidia's earnings

27.08.25 14:55 Uhr

Werte in diesem Artikel

NEW YORK, Aug. 27, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. 

Ashley Mastronardi delivers the pre-market update on August 27th

  • Equities are up this morning as investors wait for chip giant Nvidia's Q2 earnings report. The company is set to release the earnings after market close this afternoon.
  • As the most heavily weighted company in the S&P 500 at more than 8%, Nvidia's results will likely be felt by investors throughout the rest of the week and provide insight into the level of demand for AI.
  • The major averages are coming off a day of fractional gains with investors shaking off President Trump's move to fire Fed Governor Lisa Cook ahead of the Fed's next policy meeting in Mid-September.

Opening Bell
Abbott (NYSE: ABT) and the Big Ten Conference are teaming up to address the worst blood shortage in a generation

Closing Bell
Van Eck celebrates the 70th anniversary of Van Eck and its first ETF listing

Click here to download the NYSE TV App

NYSE Logo

Video - https://mma.prnewswire.com/media/2759225/NYSE_Market_Update_August_27.mp4
Logo - https://mma.prnewswire.com/media/2581322/5479702/New_York_Stock_Exchange_Logo.jpg

 

Cision View original content:https://www.prnewswire.co.uk/news-releases/nyse-content-advisory-pre-market-update--wall-street-braces-for-nvidias-earnings-302539988.html

In eigener Sache

Übrigens: Abbott Laboratories und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Ausgewählte Hebelprodukte auf Abbott Laboratories

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Abbott Laboratories

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Nachrichten zu Abbott Laboratories

Wer­bung

Analysen zu Abbott Laboratories

DatumRatingAnalyst
27.08.2020Abbott Laboratories SellGoldman Sachs Group Inc.
16.10.2018Abbott Laboratories OverweightBarclays Capital
25.01.2018Abbott Laboratories BuyStifel, Nicolaus & Co., Inc.
15.12.2017Abbott Laboratories OutperformBMO Capital Markets
19.10.2017Abbott Laboratories BuyStifel, Nicolaus & Co., Inc.
DatumRatingAnalyst
16.10.2018Abbott Laboratories OverweightBarclays Capital
25.01.2018Abbott Laboratories BuyStifel, Nicolaus & Co., Inc.
15.12.2017Abbott Laboratories OutperformBMO Capital Markets
19.10.2017Abbott Laboratories BuyStifel, Nicolaus & Co., Inc.
19.10.2017Abbott Laboratories OutperformRBC Capital Markets
DatumRatingAnalyst
23.07.2015Abbott Laboratories Equal WeightBarclays Capital
27.03.2015Abbott Laboratories Equal WeightBarclays Capital
30.01.2015Abbott Laboratories Equal WeightBarclays Capital
07.01.2013Abbott Laboratories haltenDeutsche Bank Securities
29.11.2012Abbott Laboratories neutralSarasin Research
DatumRatingAnalyst
27.08.2020Abbott Laboratories SellGoldman Sachs Group Inc.
25.10.2011Abbott Laboratories sellCitigroup Corp.
05.10.2011Abbott Laboratories sellCitigroup Corp.
22.11.2006Advanced Medical Optics sellCitigroup
11.09.2006Abbott Laboratories reduceUBS

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Abbott Laboratories nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen